The PI3K/Akt1 pathway enhances steady-state levels of FANCL

Fanconi anemia hematopoietic stem cells display poor self-renewal capacity when subjected to a variety of cellular stress. This phenotype raises the question of whether the Fanconi anemia proteins are stabilized or recruited as part of a stress response and protect against stem cell loss. Here we pr...

Full description

Saved in:
Bibliographic Details
Published inMolecular biology of the cell Vol. 24; no. 16; pp. 2582 - 2592
Main Authors Dao, Kim-Hien T., Rotelli, Michael D., Brown, Brieanna R., Yates, Jane E., Rantala, Juha, Tognon, Cristina, Tyner, Jeffrey W., Druker, Brian J., Bagby, Grover C.
Format Journal Article
LanguageEnglish
Published United States The American Society for Cell Biology 15.08.2013
Subjects
Online AccessGet full text
ISSN1059-1524
1939-4586
1939-4586
DOI10.1091/mbc.e13-03-0144

Cover

Abstract Fanconi anemia hematopoietic stem cells display poor self-renewal capacity when subjected to a variety of cellular stress. This phenotype raises the question of whether the Fanconi anemia proteins are stabilized or recruited as part of a stress response and protect against stem cell loss. Here we provide evidence that FANCL, the E3 ubiquitin ligase of the Fanconi anemia pathway, is constitutively targeted for degradation by the proteasome. We confirm biochemically that FANCL is polyubiquitinated with Lys-48–linked chains. Evaluation of a series of N-terminal–deletion mutants showed that FANCL's E2-like fold may direct ubiquitination. In addition, our studies showed that FANCL is stabilized in a complex with axin1 when glycogen synthase kinase-3β is overexpressed. This result leads us to investigate the potential regulation of FANCL by upstream signaling pathways known to regulate glycogen synthase kinase-3β. We report that constitutively active, myristoylated-Akt increases FANCL protein level by reducing polyubiquitination of FANCL. Two-dimensional PAGE analysis shows that acidic forms of FANCL, some of which are phospho-FANCL, are not subject to polyubiquitination. These results indicate that a signal transduction pathway involved in self-renewal and survival of hematopoietic stem cells also functions to stabilize FANCL and suggests that FANCL participates directly in support of stem cell function.
AbstractList Fanconi anemia hematopoietic stem cells display poor self-renewal capacity when subjected to a variety of cellular stress. This phenotype raises the question of whether the Fanconi anemia proteins are stabilized or recruited as part of a stress response and protect against stem cell loss. Here we provide evidence that FANCL, the E3 ubiquitin ligase of the Fanconi anemia pathway, is constitutively targeted for degradation by the proteasome. We confirm biochemically that FANCL is polyubiquitinated with Lys-48-linked chains. Evaluation of a series of N-terminal-deletion mutants showed that FANCL's E2-like fold may direct ubiquitination. In addition, our studies showed that FANCL is stabilized in a complex with axin1 when glycogen synthase kinase-3β is overexpressed. This result leads us to investigate the potential regulation of FANCL by upstream signaling pathways known to regulate glycogen synthase kinase-3β. We report that constitutively active, myristoylated-Akt increases FANCL protein level by reducing polyubiquitination of FANCL. Two-dimensional PAGE analysis shows that acidic forms of FANCL, some of which are phospho-FANCL, are not subject to polyubiquitination. These results indicate that a signal transduction pathway involved in self-renewal and survival of hematopoietic stem cells also functions to stabilize FANCL and suggests that FANCL participates directly in support of stem cell function.
Fanconi anemia hematopoietic stem cells display poor self-renewal capacity when subjected to a variety of cellular stress. This phenotype raises the question of whether the Fanconi anemia proteins are stabilized or recruited as part of a stress response and protect against stem cell loss. Here we provide evidence that FANCL, the E3 ubiquitin ligase of the Fanconi anemia pathway, is constitutively targeted for degradation by the proteasome. We confirm biochemically that FANCL is polyubiquitinated with Lys-48-linked chains. Evaluation of a series of N-terminal-deletion mutants showed that FANCL's E2-like fold may direct ubiquitination. In addition, our studies showed that FANCL is stabilized in a complex with axin1 when glycogen synthase kinase-3β is overexpressed. This result leads us to investigate the potential regulation of FANCL by upstream signaling pathways known to regulate glycogen synthase kinase-3β. We report that constitutively active, myristoylated-Akt increases FANCL protein level by reducing polyubiquitination of FANCL. Two-dimensional PAGE analysis shows that acidic forms of FANCL, some of which are phospho-FANCL, are not subject to polyubiquitination. These results indicate that a signal transduction pathway involved in self-renewal and survival of hematopoietic stem cells also functions to stabilize FANCL and suggests that FANCL participates directly in support of stem cell function.Fanconi anemia hematopoietic stem cells display poor self-renewal capacity when subjected to a variety of cellular stress. This phenotype raises the question of whether the Fanconi anemia proteins are stabilized or recruited as part of a stress response and protect against stem cell loss. Here we provide evidence that FANCL, the E3 ubiquitin ligase of the Fanconi anemia pathway, is constitutively targeted for degradation by the proteasome. We confirm biochemically that FANCL is polyubiquitinated with Lys-48-linked chains. Evaluation of a series of N-terminal-deletion mutants showed that FANCL's E2-like fold may direct ubiquitination. In addition, our studies showed that FANCL is stabilized in a complex with axin1 when glycogen synthase kinase-3β is overexpressed. This result leads us to investigate the potential regulation of FANCL by upstream signaling pathways known to regulate glycogen synthase kinase-3β. We report that constitutively active, myristoylated-Akt increases FANCL protein level by reducing polyubiquitination of FANCL. Two-dimensional PAGE analysis shows that acidic forms of FANCL, some of which are phospho-FANCL, are not subject to polyubiquitination. These results indicate that a signal transduction pathway involved in self-renewal and survival of hematopoietic stem cells also functions to stabilize FANCL and suggests that FANCL participates directly in support of stem cell function.
The Fanconi anemia pathway supports hematopoietic stem cell survival in response to inflammatory and metabolic stress. We show that polyubiquitination and proteasome degradation of FANCL is inhibited by Akt1 activation, revealing a potentially important mechanism for the maintenance of stem cell function. Fanconi anemia hematopoietic stem cells display poor self-renewal capacity when subjected to a variety of cellular stress. This phenotype raises the question of whether the Fanconi anemia proteins are stabilized or recruited as part of a stress response and protect against stem cell loss. Here we provide evidence that FANCL, the E3 ubiquitin ligase of the Fanconi anemia pathway, is constitutively targeted for degradation by the proteasome. We confirm biochemically that FANCL is polyubiquitinated with Lys-48–linked chains. Evaluation of a series of N-terminal–deletion mutants showed that FANCL's E2-like fold may direct ubiquitination. In addition, our studies showed that FANCL is stabilized in a complex with axin1 when glycogen synthase kinase-3β is overexpressed. This result leads us to investigate the potential regulation of FANCL by upstream signaling pathways known to regulate glycogen synthase kinase-3β. We report that constitutively active, myristoylated-Akt increases FANCL protein level by reducing polyubiquitination of FANCL. Two-dimensional PAGE analysis shows that acidic forms of FANCL, some of which are phospho-FANCL, are not subject to polyubiquitination. These results indicate that a signal transduction pathway involved in self-renewal and survival of hematopoietic stem cells also functions to stabilize FANCL and suggests that FANCL participates directly in support of stem cell function.
Author Dao, Kim-Hien T.
Rotelli, Michael D.
Rantala, Juha
Brown, Brieanna R.
Bagby, Grover C.
Tognon, Cristina
Druker, Brian J.
Yates, Jane E.
Tyner, Jeffrey W.
Author_xml – sequence: 1
  givenname: Kim-Hien T.
  surname: Dao
  fullname: Dao, Kim-Hien T.
  organization: Knight Cancer Institute, Oregon Health and Science University, Portland, OR 97239
– sequence: 2
  givenname: Michael D.
  surname: Rotelli
  fullname: Rotelli, Michael D.
  organization: Knight Cancer Institute, Oregon Health and Science University, Portland, OR 97239
– sequence: 3
  givenname: Brieanna R.
  surname: Brown
  fullname: Brown, Brieanna R.
  organization: Knight Cancer Institute, Oregon Health and Science University, Portland, OR 97239
– sequence: 4
  givenname: Jane E.
  surname: Yates
  fullname: Yates, Jane E.
  organization: Knight Cancer Institute, Oregon Health and Science University, Portland, OR 97239, Northwest VA Cancer Research Center, VA Medical Center Portland, Portland, OR 97239
– sequence: 5
  givenname: Juha
  surname: Rantala
  fullname: Rantala, Juha
  organization: Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR 97239
– sequence: 6
  givenname: Cristina
  surname: Tognon
  fullname: Tognon, Cristina
  organization: Knight Cancer Institute, Oregon Health and Science University, Portland, OR 97239
– sequence: 7
  givenname: Jeffrey W.
  surname: Tyner
  fullname: Tyner, Jeffrey W.
  organization: Knight Cancer Institute, Oregon Health and Science University, Portland, OR 97239, Department of Cell and Developmental Biology, Oregon Health and Science University, Portland, OR 97239
– sequence: 8
  givenname: Brian J.
  surname: Druker
  fullname: Druker, Brian J.
  organization: Knight Cancer Institute, Oregon Health and Science University, Portland, OR 97239, Howard Hughes Medical Institute, Oregon Health and Science University, Portland, OR 97239
– sequence: 9
  givenname: Grover C.
  surname: Bagby
  fullname: Bagby, Grover C.
  organization: Knight Cancer Institute, Oregon Health and Science University, Portland, OR 97239, Northwest VA Cancer Research Center, VA Medical Center Portland, Portland, OR 97239
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23783032$$D View this record in MEDLINE/PubMed
BookMark eNp1kVFLwzAUhYNMnJs--yZ99KVbbpM0DYIwhtPhUB_mc0jTO1ft2tl0k_17MzaHCsKFBPKdc8M5HdIqqxIJuQDaA6qgv0htD4GF1A9wfkROQTEVcpHELX-nQoUgIt4mHefe6BaJ5QlpR0wmjLLolFxP5xg8j9lDf_DeQLA0zfzTbAIs56a06ALXoMk2oWtMg0GBayxcUM2C0eBxODkjxzNTODzfn13yMrqdDu_DydPdeDiYhJYp1oQsllRyRUFiDKlJGQUBgEDTLAaWiBmPoyxObZwIxUXGUxNJlUpjBZNMUMm65Gbnu1ylC8wslk1tCr2s84WpN7oyuf79UuZz_VqtNZOcKwHe4GpvUFcfK3SNXuTOYlGYEquV08AjziLBk8Sjlz93HZZ8J-aB_g6wdeVcjbMDAlRvO9G-E-070dSPD9wrxB-FzX2cebX9bF78q_sCoq6OVw
CitedBy_id crossref_primary_10_1038_s41417_024_00797_1
crossref_primary_10_1016_S1474_4422_14_70171_1
crossref_primary_10_1016_j_bbadis_2022_166453
crossref_primary_10_1038_s41419_020_03082_9
crossref_primary_10_1038_s41467_025_56967_8
Cites_doi 10.1038/ng1241
10.1056/NEJM198910263211707
10.1523/JNEUROSCI.4474-04.2005
10.1089/10430349950016988
10.2174/1389450110607011377
10.1016/0006-291X(85)90391-2
10.1182/blood-2008-03-147090
10.1016/j.bcmd.2008.02.004
10.1016/S0092-8674(01)00374-9
10.4161/cc.3.2.656
10.1074/jbc.M111.244632
10.1182/blood-2002-07-2069
10.1073/pnas.0900189106
10.1038/mt.2009.26
10.1016/j.bbamcr.2012.08.017
10.1146/annurev-genet-102108-134222
10.18632/oncotarget.240
10.1182/blood-2011-11-388355
10.1182/blood-2011-07-366203
10.1038/nsmb.1759
10.1182/blood-2004-03-1094
10.1371/journal.ppat.1000619
10.1038/sj.mt.6300033
10.1002/jlb.52.3.357
10.1074/jbc.M511411200
10.1038/cdd.2011.16
10.1182/blood.V94.1.1.413k03_1_8
10.1038/nsmb.2173
10.1038/nature10192
10.1182/blood-2009-10-246694
10.1172/JCI58321
10.1172/JCI31772
10.3390/microarrays2020097
10.1002/ajh.2830420211
10.4049/jimmunol.147.8.2586
10.1093/emboj/16.13.3797
10.1016/j.molcel.2008.12.003
10.1038/nprot.2010.9
10.1182/blood-2006-03-007997
10.1046/j.1537-2995.1990.30891020324.x
10.1182/blood-2003-01-0114
10.1242/jcs.003152
10.1111/j.1365-2443.2007.01054.x
10.1038/nature11368
10.1182/blood-2004-06-2483
10.1182/blood.V83.5.1216.1216
ContentType Journal Article
Copyright 2013 Dao This article is distributed by The American Society for Cell Biology under license from the author(s). Two months after publication it is available to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Creative Commons License ( ). 2013
Copyright_xml – notice: 2013 Dao This article is distributed by The American Society for Cell Biology under license from the author(s). Two months after publication it is available to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Creative Commons License ( ). 2013
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1091/mbc.e13-03-0144
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic

CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1939-4586
EndPage 2592
ExternalDocumentID PMC3744951
23783032
10_1091_mbc_e13_03_0144
Genre Research Support, U.S. Gov't, Non-P.H.S
Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: 4R00CA151457
– fundername: NCATS NIH HHS
  grantid: UL1 TR000128
– fundername: Howard Hughes Medical Institute
– fundername: NCI NIH HHS
  grantid: R01 CA138237
– fundername: NCI NIH HHS
  grantid: P30 CA069533
– fundername: NCI NIH HHS
  grantid: 1R01CA138237
– fundername: NHLBI NIH HHS
  grantid: 5P01 HL048546
– fundername: NHLBI NIH HHS
  grantid: K08 HL111280
– fundername: NCI NIH HHS
  grantid: R00 CA151457
– fundername: NHLBI NIH HHS
  grantid: P01 HL048546
GroupedDBID ---
123
18M
29M
2WC
34G
39C
4.4
5RE
5VS
AAYXX
ABDNZ
ABSQV
ACGFO
ADBBV
ADNWM
AEILP
AENEX
AFHIN
AFOSN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
CITATION
CS3
D0L
DIK
DU5
E3Z
EBS
EJD
F5P
F9R
GX1
H13
HH5
HYE
IH2
INIJC
KQ8
R0Z
RPM
SJN
TCB
TR2
W8F
WOQ
YHG
YKV
YNT
YQT
YWH
.GJ
3O-
53G
ACYGS
AFFNX
C1A
CGR
CUY
CVF
ECM
EIF
IAO
IGS
IHR
ITC
NPM
OHT
ZGI
ZXP
7X8
5PM
ID FETCH-LOGICAL-c393t-3670749017e61bab301511e10bd61385f462d6bc685945d4ba279b7ac53735073
ISSN 1059-1524
1939-4586
IngestDate Thu Aug 21 18:43:16 EDT 2025
Fri Sep 05 11:10:16 EDT 2025
Thu Apr 03 06:54:35 EDT 2025
Tue Jul 01 02:18:55 EDT 2025
Thu Apr 24 22:56:54 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 16
Language English
License “ASCB®,” “The American Society for Cell Biology®,” and “Molecular Biology of the Cell®” are registered trademarks of The American Society of Cell Biology.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c393t-3670749017e61bab301511e10bd61385f462d6bc685945d4ba279b7ac53735073
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC3744951
PMID 23783032
PQID 1424325488
PQPubID 23479
PageCount 11
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3744951
proquest_miscellaneous_1424325488
pubmed_primary_23783032
crossref_primary_10_1091_mbc_e13_03_0144
crossref_citationtrail_10_1091_mbc_e13_03_0144
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2013-08-15
PublicationDateYYYYMMDD 2013-08-15
PublicationDate_xml – month: 08
  year: 2013
  text: 2013-08-15
  day: 15
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Molecular biology of the cell
PublicationTitleAlternate Mol Biol Cell
PublicationYear 2013
Publisher The American Society for Cell Biology
Publisher_xml – name: The American Society for Cell Biology
References Abrahamsson AE (B2) 2009; 106
Zhang X (B46) 2007; 120
Kockeritz L (B20) 2006; 7
Meetei AR (B31) 2003; 35
Tulpule A (B43) 2010; 115
Kelly PF (B19) 2007; 15
Korkina LG (B21) 1992; 52
Meetei AR (B32) 2004; 3
Moldovan GL (B33) 2009; 43
Dao KH (B9) 2012; 120
Aberle H (B1) 1997; 16
Rosado IV (B37) 2011; 18
Li X (B29) 2005; 105
Kee Y (B18) 2012; 122
Garaycoechea JI (B12) 2012; 489
Auerbach AD (B4) 1990; 30
Livingston CM (B28) 2009; 5
Larghero J (B23) 2002; 100
Rantala J (B35) 2013; 2
Alpi AF (B3) 2008; 32
Broxmeyer HE (B5) 1991; 147
Schultz JC (B40) 1993; 42
Gurtan AM (B14) 2006; 281
Polak R (B34) 2012; 119
Scarpa M (B39) 1985; 130
Seki S (B41) 2007; 12
Dajani R (B8) 2001; 105
Zhang X (B45) 2008; 112
Cole AR (B7) 2010; 17
Raya A (B36) 2010; 5
Martelli AM (B30) 2012; 1823
Langevin F (B22) 2011; 475
Dufour C (B11) 2003; 102
Rosselli F (B38) 1994; 83
Haneline LS (B15) 1999; 94
Hodson C (B16) 2011; 286
Li X (B25) 2004; 104
de Bie P (B10) 2011; 18
Liu JM (B27) 1999; 10
Lim KL (B26) 2005; 25
Gluckman E (B13) 1989; 321
Si Y (B42) 2006; 108
Jacome A (B17) 2009; 17
Li J (B24) 2007; 117
Yilmaz OH (B44) 2008; 41
Chappell WH (B6) 2011; 2
References_xml – volume: 35
  start-page: 165
  year: 2003
  ident: B31
  publication-title: Nat Genet
  doi: 10.1038/ng1241
– volume: 321
  start-page: 1174
  year: 1989
  ident: B13
  publication-title: N Engl J Med
  doi: 10.1056/NEJM198910263211707
– volume: 25
  start-page: 2002
  year: 2005
  ident: B26
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.4474-04.2005
– volume: 10
  start-page: 2337
  year: 1999
  ident: B27
  publication-title: Hum Gene Ther
  doi: 10.1089/10430349950016988
– volume: 7
  start-page: 1377
  year: 2006
  ident: B20
  publication-title: Curr Drug Targets
  doi: 10.2174/1389450110607011377
– volume: 130
  start-page: 127
  year: 1985
  ident: B39
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/0006-291X(85)90391-2
– volume: 112
  start-page: 1683
  year: 2008
  ident: B45
  publication-title: Blood
  doi: 10.1182/blood-2008-03-147090
– volume: 41
  start-page: 73
  year: 2008
  ident: B44
  publication-title: Blood Cells Mol Dis
  doi: 10.1016/j.bcmd.2008.02.004
– volume: 105
  start-page: 721
  year: 2001
  ident: B8
  publication-title: Cell
  doi: 10.1016/S0092-8674(01)00374-9
– volume: 3
  start-page: 179
  year: 2004
  ident: B32
  publication-title: Cell Cycle
  doi: 10.4161/cc.3.2.656
– volume: 286
  start-page: 32628
  year: 2011
  ident: B16
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M111.244632
– volume: 100
  start-page: 3051
  year: 2002
  ident: B23
  publication-title: Blood
  doi: 10.1182/blood-2002-07-2069
– volume: 106
  start-page: 3925
  year: 2009
  ident: B2
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0900189106
– volume: 17
  start-page: 1083
  year: 2009
  ident: B17
  publication-title: Mol Ther
  doi: 10.1038/mt.2009.26
– volume: 1823
  start-page: 2168
  year: 2012
  ident: B30
  publication-title: Biochim Biophys Acta
  doi: 10.1016/j.bbamcr.2012.08.017
– volume: 43
  start-page: 223
  year: 2009
  ident: B33
  publication-title: Annu Rev Genet
  doi: 10.1146/annurev-genet-102108-134222
– volume: 2
  start-page: 135
  year: 2011
  ident: B6
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.240
– volume: 120
  start-page: 323
  year: 2012
  ident: B9
  publication-title: Blood
  doi: 10.1182/blood-2011-11-388355
– volume: 119
  start-page: 911
  year: 2012
  ident: B34
  publication-title: Blood
  doi: 10.1182/blood-2011-07-366203
– volume: 17
  start-page: 294
  year: 2010
  ident: B7
  publication-title: Nat Struct Mol Biol
  doi: 10.1038/nsmb.1759
– volume: 104
  start-page: 1204
  year: 2004
  ident: B25
  publication-title: Blood
  doi: 10.1182/blood-2004-03-1094
– volume: 5
  start-page: e1000619
  year: 2009
  ident: B28
  publication-title: PLoS Pathog
  doi: 10.1371/journal.ppat.1000619
– volume: 15
  start-page: 211
  year: 2007
  ident: B19
  publication-title: Mol Ther
  doi: 10.1038/sj.mt.6300033
– volume: 52
  start-page: 357
  year: 1992
  ident: B21
  publication-title: J Leukoc Biol
  doi: 10.1002/jlb.52.3.357
– volume: 281
  start-page: 10896
  year: 2006
  ident: B14
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M511411200
– volume: 18
  start-page: 1393
  year: 2011
  ident: B10
  publication-title: Cell Death Differ
  doi: 10.1038/cdd.2011.16
– volume: 94
  start-page: 1
  year: 1999
  ident: B15
  publication-title: Blood
  doi: 10.1182/blood.V94.1.1.413k03_1_8
– volume: 18
  start-page: 1432
  year: 2011
  ident: B37
  publication-title: Nat Struct Mol Biol
  doi: 10.1038/nsmb.2173
– volume: 475
  start-page: 53
  year: 2011
  ident: B22
  publication-title: Nature
  doi: 10.1038/nature10192
– volume: 115
  start-page: 3453
  year: 2010
  ident: B43
  publication-title: Blood
  doi: 10.1182/blood-2009-10-246694
– volume: 122
  start-page: 3799
  year: 2012
  ident: B18
  publication-title: J Clin Invest
  doi: 10.1172/JCI58321
– volume: 117
  start-page: 3283
  year: 2007
  ident: B24
  publication-title: J Clin Invest
  doi: 10.1172/JCI31772
– volume: 2
  start-page: 97
  year: 2013
  ident: B35
  publication-title: Microarrays
  doi: 10.3390/microarrays2020097
– volume: 42
  start-page: 196
  year: 1993
  ident: B40
  publication-title: Am J Hematol
  doi: 10.1002/ajh.2830420211
– volume: 147
  start-page: 2586
  year: 1991
  ident: B5
  publication-title: J Immunol
  doi: 10.4049/jimmunol.147.8.2586
– volume: 16
  start-page: 3797
  year: 1997
  ident: B1
  publication-title: EMBO J
  doi: 10.1093/emboj/16.13.3797
– volume: 32
  start-page: 767
  year: 2008
  ident: B3
  publication-title: Mol Cell
  doi: 10.1016/j.molcel.2008.12.003
– volume: 5
  start-page: 647
  year: 2010
  ident: B36
  publication-title: Nat Protoc
  doi: 10.1038/nprot.2010.9
– volume: 108
  start-page: 4283
  year: 2006
  ident: B42
  publication-title: Blood
  doi: 10.1182/blood-2006-03-007997
– volume: 30
  start-page: 682
  year: 1990
  ident: B4
  publication-title: Transfusion
  doi: 10.1046/j.1537-2995.1990.30891020324.x
– volume: 102
  start-page: 2053
  year: 2003
  ident: B11
  publication-title: Blood
  doi: 10.1182/blood-2003-01-0114
– volume: 120
  start-page: 1572
  year: 2007
  ident: B46
  publication-title: J Cell Sci
  doi: 10.1242/jcs.003152
– volume: 12
  start-page: 299
  year: 2007
  ident: B41
  publication-title: Genes Cells
  doi: 10.1111/j.1365-2443.2007.01054.x
– volume: 489
  start-page: 571
  year: 2012
  ident: B12
  publication-title: Nature
  doi: 10.1038/nature11368
– volume: 105
  start-page: 3465
  year: 2005
  ident: B29
  publication-title: Blood
  doi: 10.1182/blood-2004-06-2483
– volume: 83
  start-page: 1216
  year: 1994
  ident: B38
  publication-title: Blood
  doi: 10.1182/blood.V83.5.1216.1216
SSID ssj0014467
Score 2.1235344
Snippet Fanconi anemia hematopoietic stem cells display poor self-renewal capacity when subjected to a variety of cellular stress. This phenotype raises the question...
The Fanconi anemia pathway supports hematopoietic stem cell survival in response to inflammatory and metabolic stress. We show that polyubiquitination and...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 2582
SubjectTerms Axin Protein - genetics
Axin Protein - metabolism
Cell Line
Enzyme Activation
Fanconi Anemia - metabolism
Fanconi Anemia Complementation Group L Protein - genetics
Fanconi Anemia Complementation Group L Protein - metabolism
Gene Expression
Glycogen Synthase Kinase 3 - biosynthesis
Glycogen Synthase Kinase 3 - genetics
Glycogen Synthase Kinase 3 beta
HEK293 Cells
HeLa Cells
Hematopoietic Stem Cells - metabolism
Humans
Phosphatidylinositol 3-Kinases - metabolism
Proteasome Endopeptidase Complex - metabolism
Protein Folding
Proto-Oncogene Proteins c-akt - genetics
Proto-Oncogene Proteins c-akt - metabolism
RNA Interference
RNA, Small Interfering
Signal Transduction
Ubiquitination
Title The PI3K/Akt1 pathway enhances steady-state levels of FANCL
URI https://www.ncbi.nlm.nih.gov/pubmed/23783032
https://www.proquest.com/docview/1424325488
https://pubmed.ncbi.nlm.nih.gov/PMC3744951
Volume 24
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fa9swEBZZx2AvY7-b_cKDPQyC0liSLZs9dSXBXdNsjASyJ2PZMilrnbE6jOyv351kO3bbQTcIJiiOHHQflzvpu-8IeQcpMvzxZCEdpSmnIghzGspMUQ6OMGPIGDMn-KczP1qIT0tv2esdt1hLm1IN09831pX8j1VhDOyKVbL_YNlmUhiA92BfuIKF4XprG3855icoivC9dFEkdfUr2Q50sUJjXg6MCbfUVA0NzpEfZJgbk8PZ0bQdlp7WTXIHtShTRR3Aff3dZrbZVj05u6ARNgdo6NVf10bWs8XC3_GImzT_I-TkSVEkO4biNwxzLVMXIt1xe_8Be0EE1FZgVi4zxLNkrxa0vmGs8rO2VrrGU8drerYB0TV3DsEMrOCFSodjfDAyv6xaZFc4e_Y5niym03g-Xs7vkLtMSnNiH0VNJoRZr7QEA_vDapWn0D24Mn03QLmWdVwlz7aikflD8qBKI5xDi4lHpKeLx-SebSy6fUI-ADIcRMYB4sKpcOHUuHDauHAsLpx17hhcPCWLyXh-FNGqTQZNechLihJ8UkBcJ7XvqkSBy4YoWrsjlUGsFni58Fnmq9QPvFB4mVAJk6GSSepxySEd4M_IXrEu9D5xOGabGNEFKRO-yBMdas_TkPTmKmdK98mwXps4rTTksZXJeWy5DG4Mixlrl8cjeMFi9sn75gs_rHzK3299Wy92DC4O8Q3oW28uYyzG5AxS66BPntvFbyZjXAYQhbE-kR2zNDegfHr3k-JsZWTUuRQC8osXt3juS3J_B_1XZK_8udGvIRgt1RsDsz9FNoPm
linkProvider ABC ChemistRy
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+PI3K%2FAkt1+pathway+enhances+steady-state+levels+of+FANCL&rft.jtitle=Molecular+biology+of+the+cell&rft.au=Dao%2C+Kim-Hien+T&rft.au=Rotelli%2C+Michael+D&rft.au=Brown%2C+Brieanna+R&rft.au=Yates%2C+Jane+E&rft.date=2013-08-15&rft.issn=1939-4586&rft.eissn=1939-4586&rft.volume=24&rft.issue=16&rft.spage=2582&rft_id=info:doi/10.1091%2Fmbc.E13-03-0144&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1059-1524&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1059-1524&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1059-1524&client=summon